Travere Therapeutics Grants 65,520 Restricted Stock Units to 20 New Employees

By Public Technologies
  • Travere Therapeutics granted inducement restricted stock units covering 65,520 common shares to 20 new employees on November 10, 2026.
  • The awards vest over four years, with 25% vesting on each grant-date anniversary, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611121700BIZWIRE_USPR_____20261112_BW057427) on November 12, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk